InvestorsHub Logo
Followers 254
Posts 17969
Boards Moderated 0
Alias Born 01/19/2006

Re: Whalatane post# 424456

Wednesday, 05/22/2024 6:32:30 PM

Wednesday, May 22, 2024 6:32:30 PM

Post# of 426086
DuPont is splitting 3 ways again after splitting 3 ways a few years ago. How about AMRN splitting X ways for each indication for Vascepa—does that work for one Vascepa compound, or do we also need different formulations with different dosage ranges?

We use MAGS as an investment, a less expensive magnificent 7. Selling ~ $40/share. We held NVDA, MSFT, AAPL and TSLA prior to MAGS existence.

BTW, reached 87 three+ weeks ago.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News